These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 17891366)

  • 41. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
    Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
    Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor.
    Aplin AC; Nicosia RF
    Angiogenesis; 2016 Apr; 19(2):133-46. PubMed ID: 26748649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.
    Robinson SP; Ludwig C; Paulsson J; Ostman A
    Int J Cancer; 2008 Apr; 122(7):1548-56. PubMed ID: 18033683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies.
    Yap TA; Olmos D; Brunetto AT; Tunariu N; Barriuso J; Riisnaes R; Pope L; Clark J; Futreal A; Germuska M; Collins D; deSouza NM; Leach MO; Savage RE; Waghorne C; Chai F; Garmey E; Schwartz B; Kaye SB; de Bono JS
    J Clin Oncol; 2011 Apr; 29(10):1271-9. PubMed ID: 21383285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
    Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
    Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular abnormalities of blood vessels as targets in cancer.
    Baluk P; Hashizume H; McDonald DM
    Curr Opin Genet Dev; 2005 Feb; 15(1):102-11. PubMed ID: 15661540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
    Sennino B; Falcón BL; McCauley D; Le T; McCauley T; Kurz JC; Haskell A; Epstein DM; McDonald DM
    Cancer Res; 2007 Aug; 67(15):7358-67. PubMed ID: 17671206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pericytes in Metastasis.
    Pieterse Z; Sinha D; Kaur P
    Adv Exp Med Biol; 2019; 1147():125-135. PubMed ID: 31147875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour angiogenesis regulation by the miR-200 family.
    Pecot CV; Rupaimoole R; Yang D; Akbani R; Ivan C; Lu C; Wu S; Han HD; Shah MY; Rodriguez-Aguayo C; Bottsford-Miller J; Liu Y; Kim SB; Unruh A; Gonzalez-Villasana V; Huang L; Zand B; Moreno-Smith M; Mangala LS; Taylor M; Dalton HJ; Sehgal V; Wen Y; Kang Y; Baggerly KA; Lee JS; Ram PT; Ravoori MK; Kundra V; Zhang X; Ali-Fehmi R; Gonzalez-Angulo AM; Massion PP; Calin GA; Lopez-Berestein G; Zhang W; Sood AK
    Nat Commun; 2013; 4():2427. PubMed ID: 24018975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC; Leenders WP
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biochemistry of cancer dissemination.
    Price JT; Bonovich MT; Kohn EC
    Crit Rev Biochem Mol Biol; 1997; 32(3):175-253. PubMed ID: 9239493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
    Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
    J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of pericytes in angiogenesis: focus on cancer angiogenesis and anti-angiogenic therapy.
    Chen Z; Xu XH; Hu J
    Neoplasma; 2016; 63(2):173-82. PubMed ID: 26774138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vascular perfusion as the origin of neoplasm resistance to radio- and chemotherapy].
    Martinive P; Coucke PA
    Rev Med Liege; 2010 Mar; 65(3):133-9. PubMed ID: 20411817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
    Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
    Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
    Song N; Huang Y; Shi H; Yuan S; Ding Y; Song X; Fu Y; Luo Y
    Cancer Res; 2009 Aug; 69(15):6057-64. PubMed ID: 19584297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective eradication of tumor vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis.
    Guan YY; Luan X; Xu JR; Liu YR; Lu Q; Wang C; Liu HJ; Gao YG; Chen HZ; Fang C
    Biomaterials; 2014 Mar; 35(9):3060-70. PubMed ID: 24393268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer.
    Bos R; van Diest PJ; de Jong JS; van der Groep P; van der Valk P; van der Wall E
    Histopathology; 2005 Jan; 46(1):31-6. PubMed ID: 15656883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.